Richard C Harvey
Overview
Explore the profile of Richard C Harvey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
5851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rabin K, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler J, et al.
J Clin Oncol
. 2023 Oct;
42(2):218-227.
PMID: 37890117
Purpose: Patients with Down syndrome (DS) and B-ALL experience increased rates of relapse, toxicity, and death. We report results for patients with DS B-ALL enrolled on Children's Oncology Group trials...
2.
Robinson B, Kairalla J, Devidas M, Carroll A, Harvey R, Heerema N, et al.
Haematologica
. 2023 Mar;
108(10):2865-2871.
PMID: 36861410
No abstract available.
3.
Brady S, Roberts K, Gu Z, Shi L, Pounds S, Pei D, et al.
Nat Genet
. 2022 Sep;
54(9):1376-1389.
PMID: 36050548
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we find that, despite a generally low...
4.
Advani A, Moseley A, ODwyer K, Wood B, Fang M, Wieduwilt M, et al.
J Clin Oncol
. 2022 Feb;
40(14):1574-1582.
PMID: 35157496
Purpose: Chemotherapy outcomes in older patients with Philadelphia (Ph) chromosome-negative B-acute lymphoblastic leukemia (ALL) are very poor. Here, we evaluated blinatumomab as induction and consolidation therapy followed by prednisone, vincristine,...
5.
Saint Fleur-Lominy S, Evensen N, Bhatla T, Sethia G, Narang S, Choi J, et al.
Cancer Res
. 2020 Oct;
80(23):5189-5202.
PMID: 33067268
Although B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy in children and while highly curable, it remains a leading cause of cancer-related mortality. The outgrowth of tumor subclones...
6.
Harvey R, Tasian S
Blood Adv
. 2020 Jan;
4(1):218-228.
PMID: 31935290
Philadelphia chromosome-like B-cell acute lymphoblastic leukemia (Ph-like ALL) accounts for 15% to 30% of B-cell acute lymphoblastic leukemia in older children, adolescents, and adults and is associated with high rates...
7.
Carroll A, Shago M, Mikhail F, Raimondi S, Hirsch B, Loh M, et al.
Cancer Genet
. 2019 Aug;
238:62-68.
PMID: 31425927
Hyperdiploidy with greater than 50 chromosomes is usually associated with favorable prognosis in pediatric acute lymphoblastic leukemia (ALL), whereas hypodiploidy with ≤43 chromosomes is associated with extremely poor prognosis. Sometimes,...
8.
Stock W, Luger S, Advani A, Yin J, Harvey R, Mullighan C, et al.
Blood
. 2019 Jan;
133(14):1548-1559.
PMID: 30658992
Retrospective studies have suggested that older adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) have better survival rates when treated using a pediatric ALL regimen administered by pediatric...
9.
Urtishak K, Wang L, Culjkovic-Kraljacic B, Davenport J, Porazzi P, Vincent T, et al.
Oncogene
. 2018 Nov;
38(13):2241-2262.
PMID: 30478448
The poor outcomes in infant acute lymphoblastic leukemia (ALL) necessitate new treatments. Here we discover that EIF4E protein is elevated in most cases of infant ALL and test EIF4E targeting...
10.
Roberts K, Reshmi S, Harvey R, Chen I, Patel K, Stonerock E, et al.
Blood
. 2018 Jul;
132(8):815-824.
PMID: 29997224
Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL; --like ALL) in children with National Cancer Institute (NCI) intermediate- or high-risk (HR) ALL is associated with poor outcome. Ph-like ALL is characterized...